Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 135.6M | 167.6M | 136.6M | 148.4M |
Cost of revenue | 57.8M | 73.1M | 58.3M | 63.8M |
Gross profit | 77.8M | 94.5M | 78.3M | 84.6M |
Operating expense | ||||
Research & development | 16.9M | 19.2M | 15.1M | 17.9M |
Selling general and admin | 43M | 47.4M | 39.4M | 43.3M |
Other operating expenses | — | -100K | -200K | -200K |
Operating income | 17.9M | 28M | 24M | 23.6M |
Non operating interest income | ||||
Income | 2.3M | 4.3M | 2.2M | 1.3M |
Expense | 5M | 6.1M | 1.9M | 1.8M |
Other income expense | — | — | — | — |
Pretax income | 15.1M | 26.4M | 24.5M | 23.2M |
Tax provision | 3.2M | 5.1M | 5.2M | 5.2M |
Net income | 11.9M | 21.4M | 19.2M | 17.9M |
Basic EPS | 0.3 | 0.6 | 0.5 | 0.5 |
Diluted EPS | 0.3 | 0.6 | 0.5 | 0.5 |
Basic average shares | 36.3M | 36.3M | 36.3M | 36.3M |
Diluted average shares | 36.4M | 36.4M | 36.4M | 36.4M |
EBITDA | 27.1M | 39.4M | 32.3M | 30.8M |
Net income from continuing op. | 11.9M | 21.4M | 19.2M | 17.9M |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |